Reviews/Ultra Processed Foods/Ultra-processed food raises colorectal cancer risk
Mortality Cancer · UPF-MC-03 · v2
Borderline: within 4 points of the Likely/Uncertain boundary, so a re-grade could land either side.
Across several independent observational studies, people who ate more ultra-processed food tended to have somewhat higher colorectal cancer risk. A large European cohort found a 6% higher risk per 10% more ultra-processed food [4], men in a US cohort had higher risk [1], and two case-control studies in Spain and Iran pointed the same way [10][11]. But the picture is not uniform: the single largest cohort found no link [7], and in the US study women showed no association [1]. Because all of these are observational, the apparent effect of 'processing' is hard to separate from the effects of eating more processed meat and a generally poorer diet. The panel treated the direction as positive but modest and partly confounded, which is why it stopped short of calling the link firmly settled.
Most direct tests of incidence point the same way: the EPIC cohort reports 6% higher colorectal cancer risk per 10% increment in ultra-processed food [4], US men show a 29% higher risk in the top versus bottom fifth [1], a Spanish case-control study gives an odds ratio of 1.11 per 10% [10], and a small Iranian case-control study an odds ratio of 3.32 [11]. A colon-specific EPIC analysis finds a positive association per standard deviation of 1.06 [6], and a substitution analysis shows that replacing 10% of ultra-processed food with minimally processed food lowers colon cancer risk to 0.93 [9]. Precursor-lesion data are consistent, with raised odds of adenomas (1.18) and serrated lesions (1.20) [2] and of early-onset adenomas (1.45) [3]. Against this, the largest cohort, NIH-AARP, finds no association (hazard ratios 0.91 in men, 0.93 in women) and attributes risk to diet quality rather than processing [7]. The contested point: The evidence divides on whether a distinct 'processing' effect exists or whether the signal is overall diet quality and processed-meat content relabelled: the largest cohort [7] is null and shows poor Healthy Eating Index predicts risk across all ultra-processed food quintiles, while [2] reports its association is essentially unchanged after excluding processed meat. The panel also splits on direction because women are null in the flagship US cohort [1].
All 18 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Ultra Processed Foods, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
The single largest direct cohort test, NIH-AARP (N approx 461k, [7]), found no association (HR 0.91 men, 0.93 women) and attributed CRC risk to diet quality irrespective of processing — a well-powered direct contradiction of the claim.
UPF intake is strongly confounded by processed-meat content (an established CRC carcinogen) and overall Western diet quality; [7] shows poor HEI drives CRC risk across all UPF quintiles, so the 'processing' signal may be known nutrient risk relabelled.
Where it remains uncertain. The single largest cohort, NIH-AARP, finds no association (0.91 men, 0.93 women) and attributes risk to diet quality irrespective of processing [7], and women are null in the flagship US cohort [1].
Aleatory
The Iranian case-control study gives a wide interval around its estimate (odds ratio 3.32, 1.44 to 7.61 [11]), reflecting random variation at small sample size.
Epistemic
NIH-AARP shows poor Healthy Eating Index predicts colorectal cancer risk across all ultra-processed food quintiles [7], so the processing effect cannot be cleanly separated from overall diet quality.
Inferential
Precursor-lesion, colon-only and substitution results [2][3][6][9] are extrapolated to overall colorectal cancer incidence.
The load-bearing papers from a corpus of 18, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Positive in men but null in women — shows sex heterogeneity
“men in the highest fifth of consumption had a 29% higher risk of developing colorectal cancer (hazard ratio for highest versus lowest fifth 1.29, 95% confidence interval 1.08 to 1.53; P for trend=0.01), and the positive association was limited to distal colon cancer”
Panel auditInternal validity: high · scope of inference: US health professionals and nurses; incident CRC over mid-to-late adulthood.Key limitations: association limited to men · null in women · observational confounding
Precursor (surrogate) evidence supporting a carcinogenic pathway
“those in the highest quintile had an increased risk of conventional adenomas (OR = 1.18, 95% CI = 1.11 to 1.26) and serrated lesions (OR = 1.20, 95% CI = 1.13 to 1.28).”
Panel auditInternal validity: high · scope of inference: US cohort participants undergoing endoscopy; precursor lesions rather than invasive CRC.Key limitations: precursor not cancer endpoint · single baseline endoscopy requirement
Largest direct cohort estimate; modest significant positive association
“A 10% increase in proportion of UPFs was associated with 6% higher CRC risk (95% CI:1.02-1.10).”
Panel auditInternal validity: high · scope of inference: Middle-aged European adults; incident CRC and sub-sites.Key limitations: single baseline FFQ · observational
Largest direct cohort; null result — key counter-evidence
“Higher UPF intake was not associated with higher CRC risk in men (HRQ5vs.Q1=0.91; 95% CI, 0.84-0.99; P-trend=0.32) or women (HRQ5vs.Q1=0.93; 95% CI, 0.84-1.04; P-trend=0.58) overall or by anatomic location”
Panel auditInternal validity: high · scope of inference: US adults aged 50-71; incident CRC overall and by site.Key limitations: conference abstract · attributes null to opposing effects of UPF subgroups and poor diet quality
4 of 18 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
A consistent but modest positive direction across several independent observational designs supports a likely harmful association, while one large null cohort and confounding by diet quality preclude a higher tier.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Processing effect net of diet quality. The verdict rests on a processing-specific signal, yet the largest cohort attributes risk to diet quality irrespective of processing [7]. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A pooled cohort analysis mutually adjusting ultra-processed food intake and a validated diet-quality index, with processed meat held constant, reporting the colorectal-specific estimate.
Open question: Does ultra-processed food raise colorectal cancer risk beyond what overall diet quality and processed-meat intake explain? Why it is still open: The largest cohort is null and attributes risk to diet quality across all ultra-processed food quintiles [7], while positive cohorts adjust for but cannot isolate processing [4][1].
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19